166 related articles for article (PubMed ID: 35329085)
1. Association between Clinical Use of Colchicine and Risk of Type 2 Diabetes Mellitus among Gouty Patients: A Nationwide Cohort Study.
Chu CC; Chen YC; Lin MH; Wu WT; Liu FC; Chen HC; Chou YC; Sun CA
Int J Environ Res Public Health; 2022 Mar; 19(6):. PubMed ID: 35329085
[TBL] [Abstract][Full Text] [Related]
2. Association between colchicine use and the risk of dementia among patients with gout: A nationwide retrospective cohort study.
Chen PY; Tseng CC; Lee YT; Yip HT; Chang R; Wei JC
Int J Rheum Dis; 2024 May; 27(5):e15162. PubMed ID: 38720421
[TBL] [Abstract][Full Text] [Related]
3. Association of Sodium-Glucose Transport Protein 2 Inhibitor Use for Type 2 Diabetes and Incidence of Gout in Taiwan.
Chung MC; Hung PH; Hsiao PJ; Wu LY; Chang CH; Wu MJ; Shieh JJ; Chung CJ
JAMA Netw Open; 2021 Nov; 4(11):e2135353. PubMed ID: 34797368
[TBL] [Abstract][Full Text] [Related]
4. Colchicine Significantly Reduces Incident Cancer in Gout Male Patients: A 12-Year Cohort Study.
Kuo MC; Chang SJ; Hsieh MC
Medicine (Baltimore); 2015 Dec; 94(50):e1570. PubMed ID: 26683907
[TBL] [Abstract][Full Text] [Related]
5. Gout can increase the risk of periodontal disease in Taiwan.
Chen HH; Ho CW; Hsieh MC; Chen CC; Hsu SP; Lin CL; Kao CH
Postgrad Med; 2020 Aug; 132(6):521-525. PubMed ID: 32298158
[No Abstract] [Full Text] [Related]
6. Association of gout and colorectal cancer in Taiwan: a nationwide population-based cohort study.
Chuang JP; Lee JC; Leu TH; Hidajah AC; Chang YH; Li CY
BMJ Open; 2019 Oct; 9(10):e028892. PubMed ID: 31601586
[TBL] [Abstract][Full Text] [Related]
7. Associations between urate-lowering therapy and the risk of type 2 diabetes mellitus.
Chang HW; Lin YW; Lin MH; Lan YC; Wang RY
PLoS One; 2019; 14(1):e0210085. PubMed ID: 30615649
[TBL] [Abstract][Full Text] [Related]
8. Association Between Colchicine and Risk of Diabetes Among the Veterans Affairs Population With Gout.
Wang L; Sawhney M; Zhao Y; Carpio GR; Fonseca V; Shi L
Clin Ther; 2015 Jun; 37(6):1206-15. PubMed ID: 25857595
[TBL] [Abstract][Full Text] [Related]
9. The association of dipeptidyl peptidase IV inhibitors and other risk factors with bullous pemphigoid in patients with type 2 diabetes mellitus: A retrospective cohort study.
Guo JY; Chen HH; Yang YC; Wu PY; Chang MP; Chen CC
J Diabetes Complications; 2020 Mar; 34(3):107515. PubMed ID: 31932172
[TBL] [Abstract][Full Text] [Related]
10. Effects of colchicine use on ischemic and hemorrhagic stroke risk in diabetic patients with and without gout.
Yeh JJ; Kuo IL; Yip HT; Hsueh MY; Hsu CY; Kao CH
Sci Rep; 2022 Jun; 12(1):9195. PubMed ID: 35655077
[TBL] [Abstract][Full Text] [Related]
11. Insulin use and gout risk among patients with type 2 diabetes mellitus: a real-world cohort study in Shanghai, China.
Qi J; He P; Yao H; Sun W; Lu P; Qi X; Zhang Z; Jing R; Cui B; Liu D; Ning G
Clin Rheumatol; 2023 Nov; 42(11):3067-3073. PubMed ID: 37400692
[TBL] [Abstract][Full Text] [Related]
12. Association between Non-Steroidal Anti-Inflammatory Drugs Use and the Risk of Type 2 Diabetes Mellitus: A Nationwide Retrospective Cohort Study.
Lin MH; Wu WT; Chen YC; Lu CH; Su SC; Kuo FC; Chou YC; Sun CA
J Clin Med; 2022 Jun; 11(11):. PubMed ID: 35683572
[TBL] [Abstract][Full Text] [Related]
13. Association of Traditional Chinese Medicine Therapy and the Risk of Vascular Complications in Patients With Type II Diabetes Mellitus: A Nationwide, Retrospective, Taiwanese-Registry, Cohort Study.
Lee AL; Chen BC; Mou CH; Sun MF; Yen HR
Medicine (Baltimore); 2016 Jan; 95(3):e2536. PubMed ID: 26817897
[TBL] [Abstract][Full Text] [Related]
14. Association Between Gout and Incident Type 2 Diabetes Mellitus: A Retrospective Cohort Study.
Tung YC; Lee SS; Tsai WC; Lin GT; Chang HW; Tu HP
Am J Med; 2016 Nov; 129(11):1219.e17-1219.e25. PubMed ID: 27448491
[TBL] [Abstract][Full Text] [Related]
15. Association between Gout, Urate-Lowering Therapy, and Risk of Developing Type 2 Diabetes Mellitus: A Nationwide Population-Based Retrospective Cohort Study.
Fang YJ; Chung YL; Lin CL; Lim YP
Biomed Res Int; 2020; 2020():6358954. PubMed ID: 32775432
[TBL] [Abstract][Full Text] [Related]
16. Decreased incidence of diabetes in patients with gout using benzbromarone.
Niu SW; Chang KT; Ta A; Chang YH; Kuo IC; Hung CC; Chiu YW; Hwang SJ; Lin SF; Lin HY
Rheumatology (Oxford); 2018 Sep; 57(9):1574-1582. PubMed ID: 29796661
[TBL] [Abstract][Full Text] [Related]
17. Incidence of Bladder Cancer in Type 2 Diabetes Mellitus Patients: A Population-Based Cohort Study.
Pan Y; Lee CY; Lee LM; Wen YC; Huang JY; Yang SF; Hsiao CH
Medicina (Kaunas); 2020 Aug; 56(9):. PubMed ID: 32878139
[No Abstract] [Full Text] [Related]
18. Effects of colchicine on risk of cardiovascular events and mortality among patients with gout: a cohort study using electronic medical records linked with Medicare claims.
Solomon DH; Liu CC; Kuo IH; Zak A; Kim SC
Ann Rheum Dis; 2016 Sep; 75(9):1674-9. PubMed ID: 26582823
[TBL] [Abstract][Full Text] [Related]
19. Increased Risk of Nasal Septal Abscess After Septoplasty in Patients with Type 2 Diabetes Mellitus.
Luan CW; Tsai MS; Liu CY; Yang YH; Tsai YT; Hsu CM; Wu CY; Chang PJ; Chang GH
Laryngoscope; 2021 Aug; 131(8):E2420-E2425. PubMed ID: 33325554
[TBL] [Abstract][Full Text] [Related]
20. Risk of type 2 diabetes mellitus in patients with acute critical illness: a population-based cohort study.
Hsu CW; Lin CS; Chen SJ; Lin SH; Lin CL; Kao CH
Intensive Care Med; 2016 Jan; 42(1):38-45. PubMed ID: 26370689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
